Academic Jobs - Home of Higher Ed Logo

genCARE Project Launches to Map Genomes of 11,000+ Black Canadians Targeting Type 2 Diabetes, Hypertension, and Breast Cancer

780views
Submit News
Modern building with tu/e sign and flags outside
Photo by Pourya Gohari on Unsplash

Launch of the Landmark genCARE Project

The genCARE project, short for Genomic Evidence for Precision Medicine for Selected Chronic Diseases among Black Peoples in Canada, officially launched in late January 2026 at The Hospital for Sick Children (SickKids) in Toronto. This ambitious initiative brings together leading researchers from across Ontario, Quebec, and Nova Scotia to sequence more than 11,100 genomes from Black Canadians. By focusing on individuals affected by type 2 diabetes, hypertension, and triple-negative breast cancer—as well as healthy controls—the project seeks to uncover genetic factors contributing to these conditions' disproportionate impact on Black communities.

Precision medicine, which tailors healthcare based on an individual's genetic makeup, lifestyle, and environment, has transformed treatment in many areas. However, genomic databases have historically underrepresented Black populations, with less than 5 percent of global genetic studies including sufficient data from people of African descent. This gap leads to diagnostic challenges and less effective treatments. genCARE addresses this head-on, promising more equitable health outcomes through data-driven insights.

Recruitment began immediately, targeting adults aged 18 and older who self-identify as Black, hold Canadian citizenship or permanent residency, and reside in the participating provinces. Community health centers, hospitals, and physicians' offices serve as key recruitment sites, with plans to expand to pediatric cohorts later.

Addressing Profound Health Disparities in Black Canadian Communities

Black Canadians, who make up about 4.3 percent of the population, face stark health inequities. Chronic diseases like type 2 diabetes, hypertension, and certain cancers strike at higher rates and with greater severity. For instance, the prevalence of diagnosed diabetes among Black adults is over twice that of White Canadians—approximately 2.1 to 2.3 times higher according to Public Health Agency of Canada data. Hypertension rates are similarly elevated, contributing to higher cardiovascular risks.

These disparities stem from a complex interplay of genetic predispositions, social determinants of health (such as income, housing stability, and access to nutritious food), and systemic barriers including racial bias in healthcare. Historical mistrust, rooted in events like the Tuskegee syphilis study and local experiences of discrimination, has compounded challenges in research participation. genCARE integrates these social and structural determinants alongside genomic data for a holistic approach.

In Nova Scotia's African Nova Scotian communities—some of Canada's oldest Black populations—these issues are particularly acute, with long-standing health outcome gaps. The project's emphasis on community advisory groups ensures culturally sensitive practices and transparent data sharing.

🧬 Focus on Three Key Chronic Diseases

The genCARE project prioritizes three conditions that disproportionately burden Black Canadians: type 2 diabetes (also known as adult-onset diabetes), hypertension (high blood pressure), and triple-negative breast cancer (TNBC), an aggressive subtype lacking the three common receptors targeted by standard therapies.

  • Type 2 Diabetes: A metabolic disorder where the body resists insulin or produces insufficient amounts, leading to high blood sugar. Black Canadians experience diagnosis rates up to 15 percent when including undiagnosed cases, versus 10 percent nationally. Complications include kidney failure, vision loss, and amputations.
  • Hypertension: Elevated blood pressure straining the heart and vessels, raising stroke and heart disease risks. Prevalence among Black adults exceeds 30-40 percent in some studies, far above the Canadian average of 23 percent.
  • Triple-Negative Breast Cancer: Accounts for 17-21 percent of cases in Black women, compared to 9.9 percent in White women. Mortality is 40-70 percent higher, often due to later diagnosis and poorer prognosis in younger patients.

By comparing genomes from affected individuals and controls, researchers aim to identify variants influencing disease susceptibility, severity, and treatment response.

Advanced Genomics Methods Powering Discovery

genCARE employs state-of-the-art sequencing: short-read technology for 10,000 genomes, providing high-throughput data on common variants, and long-read sequencing for 1,100 genomes to capture complex structural variations missed by shorter reads. Bioinformatics pipelines at facilities like The Centre for Applied Genomics (TCAG) at SickKids and McGill Genome Centre will analyze the data, integrating it with clinical and social determinant metrics.

The process unfolds step-by-step:

  1. Participant consent and sample collection (saliva or blood).
  2. DNA extraction and sequencing at certified labs.
  3. Variant calling and annotation using AI-enhanced tools.
  4. Association studies linking genes to phenotypes.
  5. Validation in independent cohorts and international databases.

This rigorous methodology builds on prior work, including over 3,000 genomes from Black COVID-19 studies by the same team.

Illustration of DNA sequencing process in genCARE project

Leading Canadian Universities Driving the Research

genCARE exemplifies collaborative higher education research, uniting top institutions:

  • University of Toronto / SickKids: Administrative lead Dr. Upton Allen, Professor of Pediatrics, oversees coordination. TCAG provides sequencing infrastructure.
  • McGill University / MUHC: Co-lead Dr. Loydie Jerome-Majewska, senior scientist, focuses on genomics for health disparities.
  • Dalhousie University: OmiSoore Dryden contributes expertise in community-engaged research for African Nova Scotians.
  • McMaster University: Juliet Daniel advances TNBC studies.

These universities not only host principal investigators but also train the next generation through graduate programs in genomics and public health. For aspiring researchers, projects like genCARE offer hands-on opportunities in precision medicine. Explore research jobs or research assistant positions at Canadian universities to get involved in similar initiatives.

Building Trust Through Community Engagement

Success hinges on participation, so genCARE prioritizes trust-building. Community ambassadors from centers like Black Creek Community Health Centre conduct outreach in neighborhoods like Toronto's Jane-Finch. Town halls will share findings, and data remains anonymized in Canadian servers.

Quotes underscore commitment: Dr. Upton Allen notes, "Our project lays the groundwork for more inclusive precision medicine." Cheryl Prescod of Black Creek adds, "If we are not there, we will not be counted in finding solutions." Flexible consent allows future re-contact for studies.

Robust Funding and Strategic Partnerships

Genome Canada awarded initial funding exceeding $11.7 million, matched by partners including the Black Opportunity Fund and Research Nova Scotia. Total investment nears $17.6 million, supporting sequencing, analysis, and engagement.

Key partners: Canadian Black Scientists Network, Genome Atlantic, and CGEN (Canada's Genome Enterprise Network). For details, visit the Genome Canada project page.

Funding SourceContribution
Genome Canada$8.3M+ initial
Black Opportunity FundMatching funds
Provincial (e.g., Research NS)Targeted support

Expected Impacts on Precision Health and Beyond

Discoveries could yield genetic markers for early screening, personalized drugs, and preventive strategies. Benefits include:

  • Reduced disease burden through targeted interventions.
  • Enhanced genomic databases for all Canadians.
  • Policy changes addressing anti-racist healthcare.
  • Global contributions via shared data.

For higher education, genCARE boosts Canada's genomics leadership, fostering interdisciplinary training. Students in biology, bioinformatics, and epidemiology gain real-world experience. Check career advice for academic CVs to pursue roles here.

Black Canadian community members discussing health research

Career Opportunities in Genomics and Higher Ed

This project highlights booming demand for genomics experts in Canadian universities. Postdocs, faculty, and research assistants are needed for sequencing analysis, data ethics, and community outreach. Institutions like U of T and McGill post openings regularly.

Link to postdoc jobs, faculty positions, or Canada-specific academic jobs. genCARE inspires similar equity-focused research, positioning universities as health equity leaders.

Future Outlook and Calls to Action

Over the next few years, genCARE will publish findings, host webinars, and expand. Participants can email gencare.project@sickkids.ca. Researchers, explore collaborations via university channels.

For career growth, visit Rate My Professor, higher ed jobs, and career advice. This project not only advances science but elevates Canadian higher education's role in societal good.

SickKids announcement CBC coverage
Portrait of Dr. Elena Ramirez
About the author

Dr. Elena RamirezView author

Academic Jobs In House Author

Discussion

Sort by:

Be the first to comment on this article!

You

Please keep comments respectful and on-topic.

New0 comments

Join the conversation!

Add your comments now!

Have your say

Engagement level

Browse by Faculty

Browse by Subject

Frequently Asked Questions

🧬What is the genCARE project?

The genCARE project sequences 11,100 genomes from Black Canadians to study genetic factors in type 2 diabetes, hypertension, and triple-negative breast cancer, led by universities like U of T and McGill.

📊Why focus on Black Canadians?

Black Canadians face 2x higher diabetes rates and elevated risks for hypertension and TNBC due to genetic, social factors. Less than 5% of global studies represent them adequately.

🏫Which universities are involved?

Key players: University of Toronto/SickKids, McGill University, Dalhousie University, McMaster University. Explore university jobs in genomics.

🔬How does genome sequencing work here?

Short-read for 10,000 genomes detects common variants; long-read for 1,100 captures complex structures. Data analyzed with bioinformatics at TCAG and McGill Genome Centre.

💉What are the target diseases?

Type 2 diabetes (2x prevalence), hypertension (30-40%+ rates), TNBC (17-21% in Black women vs 10% white). Aims for better prediction/prevention.

🤝How is community trust ensured?

Ambassadors, advisory groups, anonymized data in Canada, town halls for results. Builds on COVID-19 cohort success.

💰What funding supports genCARE?

Genome Canada ($11.7M+), Black Opportunity Fund, provincial matches. Total ~$17M. See Genome Canada.

🚀Expected outcomes?

Genetic markers for personalized treatments, equitable databases, policy shifts. Long-term: lower morbidity/mortality.

💼Career opportunities?

Postdocs, research assistants in genomics. Check postdoc jobs and career advice at AcademicJobs.ca.

📞How to participate?

Adults 18+, Black self-identify, Canadian status. Contact gencare.project@sickkids.ca or (416) 813-5443.

Timeline for results?

Recruitment now; analyses over years, publications ongoing. Pediatric expansion planned.